Leishmania (Viannia) braziliensis-induced chronic granulomatous cutaneous lesions affecting the nasal mucosa in the rhesus monkey (Macaca mulatta) model

The present studies on infections with Leishmania (Viannia) braziliensis in rhesus macaques were made to characterize the evolution of different parasite strains and the immune responses they elicited in this experimental host. A standardized inoculum of promastigotes was injected intradermally either above the eyelid or on the forearm of each monkey. Sixteen infected monkeys developed longstanding infections which lasted until the end of the observation period (33 months). The time required for lesion development was very variable, not only for the isolates showing molecular differences but also for individual animals in groups infected with the same parasite strain. The inocula produced lesions of variable severity, ranging from localized cutaneous leishmaniasis (CL) with a tendency to spontaneous healing to non-healing disease. One infected animal developed persistent metastatic skin and mucosal lesions. Anti-Leishmania antibodies and parasite-specific T-cell responses were induced by the experimental infections. As the granulomatous inflammatory response found at the lesions in L. (V.) braziliensis-infected M. mulatta was similar to that in patients with CL, this primate model could be useful for studying the pathophysiology and immunoregulatory events associated with disease evolution, as well as for the evaluation of new drugs or candidate vaccines.

[1]  J. Casanova,et al.  Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12‐dependent interferon‐gamma production pathway , 2002, International journal of experimental pathology.

[2]  E. Carvalhoa,et al.  Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis , 2002 .

[3]  H. Murray Tissue granuloma structure‐function in experimental visceral leishmaniasis , 2001, International journal of experimental pathology.

[4]  M. Oliveira-Neto,et al.  Leishmania (Leishmania) major-infected rhesus macaques (Macaca mulatta) develop varying levels of resistance against homologous re-infections. , 2001, Memorias do Instituto Oswaldo Cruz.

[5]  R. Coler,et al.  Protection against Cutaneous Leishmaniasis Induced by Recombinant Antigens in Murine and Nonhuman Primate Models of the Human Disease , 2001, Infection and Immunity.

[6]  F. Modabber,et al.  Vervet Monkeys Vaccinated with Killed Leishmania major Parasites and Interleukin-12 Develop a Type 1 Immune Response but Are Not Protected against Challenge Infection , 2001, Infection and Immunity.

[7]  C. Pirmez,et al.  Cell populations in lesions of cutaneous leishmaniasis of Leishmania (L.) amazonensis- infected rhesus macaques, Macaca mulatta. , 2000, Memorias do Instituto Oswaldo Cruz.

[8]  D. Sacks,et al.  Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis. , 1999, Journal of immunology.

[9]  K. Chang,et al.  Leishmania virulence and genetic heterogeneity. , 1999, Clinics in dermatology.

[10]  W. Degrave,et al.  Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. , 1998, The Journal of infectious diseases.

[11]  E. Cupolillo,et al.  Genetic diversity in natural populations of New World Leishmania. , 1998, Memorias do Instituto Oswaldo Cruz.

[12]  Arlindo L. Oliveira,et al.  Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. , 1998, The American journal of tropical medicine and hygiene.

[13]  R. Kennedy,et al.  Nonhuman primates and their potential use in immunologically based investigations , 1997 .

[14]  D. Mcmahon-Pratt,et al.  Leishmania amazonensis: the Asian rhesus macaques (Macaca mulatta) as an experimental model for study of cutaneous leishmaniasis. , 1996, Experimental parasitology.

[15]  S. Beverley,et al.  Intergenic region typing (IRT): a rapid molecular approach to the characterization and evolution of Leishmania. , 1995, Molecular and biochemical parasitology.

[16]  J. David,et al.  American cutaneous leishmaniasis: in situ characterization of the cellular immune response with time. , 1994, The American journal of tropical medicine and hygiene.

[17]  E. Carvalho,et al.  Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis. , 1994, Acta tropica.

[18]  R. Tesh,et al.  Leishmaniases of the New World: current concepts and implications for future research , 1993, Clinical Microbiology Reviews.

[19]  J. Githure,et al.  IFN‐γ and Delayed‐Type Hypersensitivity are Associated with Cutaneous Leishmaniasis in Vervet Monkeys following Secondary Rechallenge with Leishmania major , 1992, Scandinavian journal of immunology. Supplement.

[20]  G. Grimaldi júnior,et al.  Antigenic differences among Leishmania amazonensis isolates and their relationship with distinct clinical forms of the disease. , 1992, Memorias do Instituto Oswaldo Cruz.

[21]  C. Pirmez,et al.  Immunologic responsiveness in American cutaneous leishmaniasis lesions. , 1990, Journal of immunology.

[22]  V. Ferreira,et al.  Experimental infection with Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the marmoset, Callithrix penicillata (Primates:Callithricidae). , 1990, Memorias do Instituto Oswaldo Cruz.

[23]  A. Gonçalves,et al.  Recurrent lesions in human Leishmania braziliensis infection—reactivation or reinfection? , 1990, The Lancet.

[24]  C. Pirmez,et al.  Quantitative study of Leishmania braziliensis braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasis , 1990, Clinical and experimental immunology.

[25]  Á. Holguín,et al.  The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis. , 1989, The Journal of infectious diseases.

[26]  R. Badaró,et al.  Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. , 1989, The Journal of clinical investigation.

[27]  E. Fikrig,et al.  Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. , 1987, The Journal of infectious diseases.

[28]  V. Dennis,et al.  Leishmania braziliensis: development of primary and satellite lesions in the experimentally infected owl monkey, Aotus trivirgatus. , 1986, Experimental parasitology.

[29]  S. Reed,et al.  Cell mediated immunity in American cutaneous and mucosal leishmaniasis. , 1985, Journal of immunology.

[30]  P. Marsden Clinical presentations of Leishmania braziliensis braziliensis. , 1985, Parasitology today.

[31]  H. Murray,et al.  Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis. , 1984, Journal of immunology.

[32]  J. Shaw,et al.  Leishmaniasis in Brazil: XII. Observations on cross-immunity in monkeys and man infected with Leishmania mexicana mexicana, L. m. amazonensis, L. braziliensis braziliensis, L. b. guyanensis and L. b. panamensis. , 1977, The Journal of tropical medicine and hygiene.

[33]  R. Bray,et al.  Studies on the immunology and serology of leishmaniasis. II. Cross-immunity experiments among different forms of American cutaneous leishmaniasis in monkeys. , 1966, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[34]  A. M. D. Cunha Infecções experimentais na Leishmaniose Tegumentar Americana , 1944 .